Is cardiomyopathy life-threatening?

Written by Zhang Yue Mei
Cardiology
Updated on September 17, 2024
00:00
00:00

Whether cardiomyopathy poses a threat to life depends on the severity of the condition. Mild myocardial damage, if detected early, diagnosed early, and treated with effective medications in a timely manner, generally has a good prognosis, poses no threat to life, and leaves no sequelae. Severe myocardial damage, due to lack of timely treatment, can lead to serious complications such as heart failure, arrhythmias, and cardiogenic shock, which can endanger life safety. Therefore, early diagnosis, early treatment, and prevention of complications are crucial treatment measures for cardiomyopathy.

Other Voices

doctor image
home-news-image
Written by Li Hai Wen
Cardiology
42sec home-news-image

Which department should I register for cardiomyopathy?

Cardiomyopathy is a common disease in our daily lives, characterized primarily by changes in the myocardium. After being diagnosed with cardiomyopathy, many patients often ask which department they should register with at the hospital. Generally speaking, cardiomyopathy falls under cardiovascular diseases, so registration should be with the department of cardiology. Cardiologists often prescribe a cardiac echocardiogram to diagnose myocardial diseases. Conditions such as hypertrophic cardiomyopathy or dilated cardiomyopathy require a cardiac echocardiogram for detection, which is the most commonly used examination for cardiomyopathy.

doctor image
home-news-image
Written by Tang Li
Cardiology
1min 14sec home-news-image

What is the prognosis of hypertrophic cardiomyopathy?

The prognosis of hypertrophic cardiomyopathy varies greatly, and it is the primary cause of sudden death in adolescents and athletes because it can progress to end-stage heart failure. Additionally, a small percentage may experience heart failure, atrial fibrillation, and embolism, but many patients have mild symptoms and can have a life expectancy close to normal. For the treatment of hypertrophic cardiomyopathy, adequate sudden death risk assessment and ICD prevention should be conducted. Because hypertrophic cardiomyopathy is the most common cause of sudden cardiac death in young people and athletes, an ICD can effectively prevent the occurrence of sudden death. Preventing high-risk factors, including previous cardiac arrest, one or more sudden deaths in first-degree relatives, severe left ventricular hypertrophy, and findings of repetitive non-sustained ventricular tachycardia on a 24-hour Holter monitor, low blood pressure during exercise, and unexplained syncope, especially during exercise, poses a high risk of sudden death in these patients.

doctor image
home-news-image
Written by Li Hai Wen
Cardiology
44sec home-news-image

Is dilated cardiomyopathy more serious or is myocardial ischemia more serious?

This has to be judged comprehensively based on the following conditions: First, the age factor. If it occurs in young people, dilated cardiomyopathy tends to be more severe. This is because dilated cardiomyopathy is an organic heart disease, and myocardial ischemia in young people may not necessarily involve organic heart disease changes, but could also be normal physiological changes in the electrocardiogram. Second, whether there is concurrent cardiac function impairment. Dilated cardiomyopathy definitely involves impairment of the heart's pumping function, whereas myocardial ischemia does not necessarily involve such impairment. Therefore, in most cases, dilated cardiomyopathy is more serious.

doctor image
home-news-image
Written by Li Hai Wen
Cardiology
52sec home-news-image

The difference between cardiomyopathy and coronary heart disease

Cardiomyopathy refers to a type of disease characterized primarily by organic changes in the myocardium, such as dilated cardiomyopathy, hypertrophic cardiomyopathy, and restrictive cardiomyopathy. These diseases are characterized mainly by pathological changes in the myocardium itself, forming a category of heart diseases. In contrast, coronary heart disease often refers to a type of heart disease caused by the narrowing of the coronary arteries due to atherosclerosis, leading to insufficient blood supply to the heart. Cardiomyopathy often manifests as damage to the myocardium, while coronary heart disease often manifests as blockage of the blood vessels. This is the fundamental difference between these two categories of heart diseases.

doctor image
home-news-image
Written by Liu Yong
Cardiology
1min 53sec home-news-image

Does cardiomyopathy require surgery?

Firstly, whether myocardial disease requires surgery, we need to clarify the type of myocardial disease and the stage of myocardial disease, that is, the stage of heart function that has been affected. There are many types of myocardial diseases, including dilated cardiomyopathy, ischemic cardiomyopathy, and restrictive cardiomyopathy, for instance. The treatment plans for different types of myocardial diseases are not exactly the same. For example, dilated cardiomyopathy is generally treated with medication, and only in the very late stages of dilated cardiomyopathy, or what is known as stage IV heart function, when conventional medication is ineffective, heart transplantation might be considered if a donor is available and conditions allow. However, currently, heart donors are extremely rare, making this option quite difficult to achieve. The latest advances in clinical research have introduced artificial mechanical hearts available for transplantation, but the costs of surgery are very high, and the technology is not very mature yet. Therefore, the chances and opportunities for surgery are not very great and must be decided based on the situation. For other conditions, such as ischemic cardiomyopathy, if it is clearly caused by severe ischemia, we might consider addressing the factors causing myocardial ischemia, such as performing a coronary angiography. If there is severe coronary artery stenosis, we might consider implementing a coronary artery stent or coronary artery bypass grafting to alleviate the ischemic factors. In cases like restrictive cardiomyopathy, if there are severe restrictive factors contributing to the disease, surgical treatment might also be pursued.